Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Medicare Drug Benefit: Impact on States, and Cost Containment

Medicare Drug Benefit: Impact on States, and Cost Containment

This presentation outlines key Medicare Modernization Act issues for Medicaid, State Pharmaceutical Assistance Programs, other state agencies, and state employee retiree benefit plans. It also reviews Medicaid cost-containment options being considered in the states related to eligibility, benefits, unit cost, utilization, managed care, revenue enhancement and cost avoidance, and administrative efficiencies.

Newsletter Volume

E.V.I.dently July 2015

NPC MessageWho Can Say What, and When? Could We See Changes in Biopharmaceutical Communications?It’s possible that 2015 could be the year that we see...
Newsletter Volume

E.V.I.dently June 2015

NPC MessageDriving Health System Value Through Broader Access to DataFrom Fitbits to insurance claims databases, we capture an enormous amount of...
Blog Post

Medicare Part D – A Beacon or a Warning Light?

The Medicare Part D prescription drug program has by nearly every measure been a success, but there is room for improvement, particularly when it...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Press Release

Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management

Washington, D.C. (December 4, 2014)—A case study published in the December 2014 issue of the Journal of Managed Care & Specialty Pharmacy...
Press Release

Fellowship in Policy Impact of Comparative Effectiveness Research Awarded By National Pharmaceutical Council and George Washington University

[[{"fid":"25703","view_mode":"teaser","type":"media","link_text":null,"attributes":{"height":"360","width":"240","border":"0","alt":"chuck-shih","...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
YouTube Videos

NHC's Boutin: Measuring Health Outcomes & Patient Aspirations

Marc Boutin, JD, CEO, National Health Council, emphasizes the need to ensure that we are integrating a patient’s perspective at the time that we are...
YouTube Videos

NHC's Boutin: Incorporating Patient Aspirations With Medical Outcomes

Marc Boutin, JD, CEO, National Health Council, says while medical outcomes are critical to patients with chronic illnesses, it's also important for...
YouTube Videos

Why are quality measures important? We asked health care thought leaders to tell us why.

Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using to promote system-wide improvement....
YouTube Videos

Shifting the Focus From "How Much" to "How Well" We Spend Our Health Care Dollars

A. Mark Fendrick, MD, director of the Center for Value-Based Insurance design at the University of Michigan, highlights the key findings from a...
Blog Post

Medicare Part D – A Beacon or a Warning Light?

The Medicare Part D prescription drug program has by nearly every measure been a success, but there is room for improvement, particularly when it...
Blog Post

CER Tweets of the Week (May 18-22): CER Stakeholders Tweet Discussions From #ISPORPhila; Generalizing RCT Results to Wider Populations

This week, many comparative effectiveness research (CER) stakeholders attended the International Society for Pharmacoeconomics and Outcomes Research...
Blog Post

#TBT: Mental Health Month—Managing Schizophrenia

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...

Consumer-Directed Health Plans: Pharmacy Benefits & "Better Practices"

On behalf of the National Pharmaceutical Council, Th

Transparency in Evidence Evaluation and Formulary Decision-Making

Although the type of evidence required to make healt

  •  
  • 1 of 47
  • >